Vizgen is proud to launch the MERFISH 2.0 World Immunotherapy Council (APAC) Grant Programme, designed to support innovative spatial transcriptomics research across the Asia-Pacific region. For over a decade, MERFISH has been the trusted foundation of spatial transcriptomics, revolutionising how researchers visualise the molecular architecture of cells. Now, MERFISH 2.0 builds on that legacy with advanced chemistry that delivers deeper, more precise insights into tissue biology.

This grant features the MERSCOPE® V2.0 Pre-designed Human ImmunoOncology Panel (815 genes)—a powerful solution to explore immune complexity, spatial cellular organisation, and dynamic tissue states with unmatched sensitivity and specificity.